id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-P-0474-0003,FDA,FDA-2004-P-0474,FDA/CDER to King & Spalding LLP,Other,LET-Letter,2004-12-13T05:00:00Z,2004,12,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce2
FDA-2004-P-0474-0002,FDA,FDA-2004-P-0474,FDA/ DDM to King & Spalding LLP,Other,ACK-Acknowledgement Letter,2004-06-10T04:00:00Z,2004,6,,,2008-04-12T00:50:25Z,,0,0,0900006480475ce1
FDA-2004-P-0474-0001,FDA,FDA-2004-P-0474,FDA/ DDM to King & Spalding LLP,Other,ACK-Acknowledgement Letter,2004-06-10T04:00:00Z,2004,6,,,2008-04-12T00:50:25Z,,0,0,0900006480475cd7